Early Increased Platelet Count Is a Predictive Factor for a Long-Term Response in High-Dose Dexamethasone Treatment for Newly-Diagnosed Immune Thrombocytopenia Patients.

被引:0
|
作者
Ishiyama, Midori
Shiseki, Masayuki
Hagiwara, Shotaro
Yoshinaga, Kentaro
Tanaka, Junji
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1050
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients
    Ishiyama, Midori
    Shiseki, Masayuki
    Yoshinaga, Kentaro
    Ryuzaki, Michiko
    Izuka, Yuki
    Watanabe, Aya
    Tanaka, Norina
    Shinohara, Akihito
    Hagiwara, Shotaro
    Tanaka, Junji
    ACTA HAEMATOLOGICA, 2022, 145 (02) : 193 - 200
  • [2] Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, David
    Herrera-Rojas, Miguel A.
    Jaime-Perez, Jose C.
    Gomez-De Leon, Andres
    Cantu-Rodriguez, Olga G.
    Gutierrez-Aguirre, Cesar H.
    Tarin-Arzaga, Luz
    Hernandez-Reyes, Jesus
    Ruiz-Arguelles, Guillermo J.
    BLOOD, 2014, 123 (25) : 3906 - 3908
  • [3] Long-term survival in newly-diagnosed ovarian cancer patients.
    Szamreta, Elizabeth A.
    Li, Yeran
    Monberg, Matthew J.
    Othus, Megan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17543 - E17543
  • [4] Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia
    Coronado-Alejandro, Edgar Ulises
    Martinez-Hernandez, Juan Pablo
    Gomez-De Leon, Andres
    Colunga-Pedraza, Perla Rocio
    Jaime-Perez, Jose Carlos
    Cantu-Rodriguez, Olga Graciela
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (06) : 778 - 779
  • [5] Rituximab Combined with 3 Cycles of High Dose Dexamethasone Improves Response in Patients with Newly-Diagnosed, Persistent, and Chronic Immune Thrombocytopenia (ITP)
    Elstrom, Rebecca L.
    Seery, Caroline
    Moll, Christina
    Miller, Allison
    Gabor, Julia
    Maffezzoli, Daniel
    Basciano, Paul Andrew
    Ghanima, Waleed
    Bussel, James B.
    BLOOD, 2012, 120 (21)
  • [6] Low-dose rituximab, eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, D.
    Colunga-Pedraza, P. R.
    Cantu-Rodriguez, O. G.
    Jaime-Perez, J. C.
    Gutierrez-Aguirre, C. H.
    Tarin-Arzaga, L.
    Sanchez-Cardenas, M.
    Sotomayor-Duque, G.
    Lozano-Morales, R. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 50 - 51
  • [7] Long-Term Effect of High-Dose Dexamethasone with or without Low-Dose Dexamethasone Maintenance in Untreated Immune Thrombocytopenia
    Din, Banhe
    Wang, Xingwen
    Shi, Yuye
    Li, Yufeng
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 124 - 128
  • [8] Long-term treatment of newly-diagnosed multiple myeloma with low-dose thalidomide, dexamethasone and zoledronate (TDZ).
    Klueppelberg, U
    Shapira, I
    Chen, L
    Aloba, MC
    Smith, E
    Palanisamy, N
    Schmidt, J
    Moezi, M
    Batuman, O
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 608S - 608S
  • [9] Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study
    Colunga-Pedraza, Perla R.
    De la Garza-Salazar, Fernando
    Vaquera-Alfaro, Hector A.
    Gomez-De Leon, Andres
    Bustillos-Munoz, Monica
    Tarin-Arzaga, Luz
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [10] The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients
    Liu, Hongyun
    Liu, Xiaoyan
    Zhang, Guoyang
    Wang, Jieyu
    Naren, Duolan
    Xie, Shuangfeng
    Li, Yiqing
    Nie, Danian
    Li, Zhixiong
    Ma, Liping
    THROMBOSIS RESEARCH, 2022, 218 : 157 - 168